Peyton Sandroni, Phd Email & Phone Number

Chapel Hill, Nc, Us

Raleigh, North Carolina, United States

Partner with small and mid-size pharma and biotech companies (53+) to accelerate clinical development across therapeutic areas, treatment modalities (i.e., small molecule, biologic, ATMP), and Phases (1-3)Author clinical development plans (CDP), target product profiles (TPP), study synopses and protocolsPerform portfolio reviews to identify key candidates and indications for early phase clinical developmentAnalyze clinical trial landscape for fluid and electrophysiological biomarker signatures and effect sizesDraft scientific/clinical content for regulatory interface (i.e., meeting request, briefing book, Investigator’s Brochure [IB]) and special program applications (e.g., Fast Track, Accelerated Approval, Breakthrough)Engage internal and external key opinion leaders (KOLs) and investors for feedback on program designPromote corporate objectives via pitch decks, manuscripts, infographics, and poster presentationsSpecialize in cardiovascular and metabolic indications: hypertension, obesity, type 2 diabetes, heart failure (HFpEF), metabolic dysfunction-associated steatohepatitis (MASH/NASH), chronic kidney disease

Chapel Hill, North Carolina, United States

Unc Mcallister Heart Institute

Jensen Lab | Dr. Brian Jensen, MD• Identify novel mechanism of α1A adrenergic receptor (α1A-ARs) regulation of fatty acid oxidation and electron transport chain activity in the mouse heart• Investigate risk of commonly prescribed α1 blockers using retrospective analysis of patient records to identify increased risk of heart failure in middle- and advanced-age men• Forge collaboration with mitochondrial expert Kelsey Fisher-Wellman, PhD at Eastern Carolina University to establish metabolism-based research pipeline using enzyme assays and respirometry• Elucidate mechanisms of MEK inhibitor cardiotoxicity underlying heart failure development in patients receiving chemotherapy

Cary, North Carolina, United States

-Assist Regulatory and Drug Development Consulting Team-Compile Clinical Study Reports and New Drug Applications for FDA submission and approval-Research clinical landscapes and novel product indications-Attend interdisciplinary and interactive Fellows’ training sessions on regulatory affairs, medical writing, project management, clinical trial monitoring, clinical pharmacology, biostatistics, clinical trial operations, and drug development strategies

Department Of Biomedical Engineering

Matrix Biology and Engineering Lab | Dr. Thomas Barker, PhD

Doctor Of Philosophy - Phd, Pharmacology

THESIS: The Alpha-1A Adrenergic Receptor Regulates Oxidative Metabolism in the Mouse Heart (UNC McAllister Heart Institute | Dr. Brian.

Bachelor Of Science - Bs, Biomedical Engineering, High Distinction

MINOR: Spanish Language (UVA in Valencia Study Abroad Program) BME THESIS: Developing a Collagen-Based Scaffold for the Healing.

Advanced Studies Diploma